Monopar Therapeutics MNPR
NASDAQ MNPR
$72.58 +0.23 (+0.32%)
At close: Oct 22, 2026 · 4:00 PM EDT

Monopar Therapeutics (MNPR) Price to Sales (2020 - 2024)

Updated

Analysis

Monopar Therapeutics (MNPR) Price to Sales (2020 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Monopar Therapeutics 620.01 Mn 338.24 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 35.11
Mar 31, 2024 28.26
Dec 31, 2023 11.26
Sep 30, 2023 284.02
Sep 30, 2022 2,146.39
Jun 30, 2022 14,731.06
Dec 31, 2021 111.66
Sep 30, 2021 165.03
Jun 30, 2021 126.29
Mar 31, 2021 89.03
Dec 31, 2020 219.97
Sep 30, 2020 198.52
Jun 30, 2020 862.26
Mar 31, 2020 1,686.49
API Access

Monopar Therapeutics Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=MNPR&period=max&api_key=YOUR_API_KEY